Close

Aegis Capital Notes 'Uneventful' Q3 for Aerie Pharma (AERI); Rhopressa NDA Now Expected in Jan. '17

Go back to Aegis Capital Notes 'Uneventful' Q3 for Aerie Pharma (AERI); Rhopressa NDA Now Expected in Jan. '17